Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PARICALCITOL vs PATISIRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PARICALCITOL vs PATISIRAN: Safety Overview

Metric PARICALCITOL PATISIRAN
Total FAERS Reports 6,665 2,708
Deaths Reported 4,801 384
Death Rate 72.0% 14.2%
Hospitalizations 1,662 1,050
Average Patient Age 57.8 yrs 65.6 yrs
% Female Patients 43.1% 34.2%
FDA Approval Date Apr 17, 1998 Aug 10, 2018
Manufacturer Aurobindo Pharma Limited Alnylam Pharmaceuticals, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription